Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Previously Treated Myelodysplastic Syndrome
Age: Between 18 - 100 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required